NASDAQ:SPRB
Spruce Biosciences, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.sprucebiosciences.comipo date
Oct 09, 2020
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus